Dermatology

Scratching the Surface: Stem Cell Therapy in Veterinary Dermatology

Learn the current evidence and potential future applications of mesenchymal stromal cell (MSC) therapy in veterinary dermatology.

July 29, 7PM ET
1 CE Credit
Coming Soon Register Now
Dr. Rebecca Windsor
Rebecca Windsor
DVM, DACVIM (Neurology)
Vice President of Veterinary Affairs at Gallant

About the Course

This lecture explores the skin as an immune organ that depends on a delicate balance among the epidermal barrier, immune system, and skin microbiome to maintain health. Participants will review potential applications of mesenchymal stromal cells (MSCs) in veterinary dermatology, with a focus on conditions such as atopic dermatitis and chronic wound healing.

This program has been RACE approved (20-1381677) for 1 hour of continuing education credit for veterinarians and veterinary technicians/technologists in jurisdictions that recognize RACE approval.

Learning objectives

  • Describe the immune–barrier–microbiome triad and explain how dysregulation of each component contributes to allergic, immune-mediated, and wound-related dermatological disease in companion animals.
  • Summarize the mechanisms by which MSCs modulate cutaneous immunity, restore epidermal barrier integrity, and support wound healing across the phases.
  • Compare the major MSC delivery routes used in veterinary dermatology.
  • Review the current veterinary evidence base for MSC therapy in canine atopic dermatitis and other dermatological diseases.

Related reading

  1. Stem Cell Therapy for Canine Atopic Dermatitis (CAD): Investigating a New Way to Help Dogs with Chronic Itchy Skin
  2. The 411 on atopic dermatitis
  3. Regenerative Medicine in Veterinary Practice: Perceptions, Experience, and Outlook
  4. Busting Myths Around Stem Cell Therapy

Start Learning Now

Explore courses, grow your skills, and earn CE credits - all at your pace.

What our learners say about growing their skills and reaching new goals.

About the presenter

Dr. Rebecca Windsor

Rebecca Windsor

DVM, DACVIM (Neurology)
Vice President of Veterinary Affairs at Gallant

Dr. Rebecca Windsor, DVM, DACVIM (Neurology), earned her veterinary degree from the University of California, Davis, in 2005. She completed a small animal medicine and surgery internship at North Carolina State University (2005–2006) and a residency in neurology and neurosurgery at UC Davis (2006–2009), achieving board certification through the American College of Veterinary Internal Medicine in 2009.

Dr. Windsor has extensive experience working in private specialty hospitals in the Washington, D.C. area, the San Francisco Bay Area, and Chicago. Most recently, she served as Chief of the Neurology Department and Neurology Internship Coordinator at Wheat Ridge Animal Hospital in Colorado. In 2024, she was honored as a “Best in Colorado Top Doctor” for excellence in veterinary medicine.

Deeply passionate about clinical research and education, Dr. Windsor has authored numerous publications and has been a Clinician Scientist with Ethos Discovery, a nonprofit scientific incubator, since 2021. She currently leads Ethos Discovery’s neurology research portfolio, focusing on immune-mediated neuroinflammatory diseases, particularly early detection and treatment strategies for necrotizing meningoencephalitis in dogs. In 2024, she was appointed the Ethos Discovery House Officer Research Project Coordinator, and she currently mentors over 100 veterinary interns and residents in clinical research.

In 2025, Dr. Windsor joined Gallant as Director of Veterinary Affairs, where she is dedicated to advancing veterinary medicine and educating the veterinary community on the therapeutic potential of stem cell therapy.

Continue Learning

See all

Current Evidence for Regenerative Medicine in Canine and Feline Osteoarthritis

Discover the biology and immunology of osteoarthritis and gain practical guidance on using regenerative medicine for early intervention.

Speakers: Marie Bartling, DVM, CVMA, CCRT, CVPP
Duration: 1h

Uterine-Derived Stem Cells for the Management of Refractory Feline Chronic Gingivostomatitis

Explore current treatment approaches for FCGS and examine clinical trial outcomes using uterine-derived stem cell therapy.

Speakers: MJ Redman, DVM, DAVDC
Duration: 1h

Stem Cell Therapy for Oral Diseases

Learn how stem cells may address immune-driven oral diseases, including FCGS, periodontitis, canine chronic ulcerative stomatitis, and others.

Speakers: Rebecca Windsor, DVM, DACVIM (Neurology)
Duration: 1h